$INDP

$3.34 +$0.01 (0.3%) Close

$INDP Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 133.2M shares outstanding

Who owns INDP?

By type of holder

Institutions 0.0% Insiders 13.8% Everyone else 86.2%

Concentration Top 10 holders own 83.4%

Yao Yun 31.5% · Sino Lion Ventures Ltd 29.2%

Institutional ownership

0.0%

0.0 pts vs last qtr

Institutional holders

0 vs last qtr

Net shares bought

by institutions in Q2 2026

New / sold out

0 / 0

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

None.

Biggest sellers in Q2 2026

None.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Indaptus Therapeutics Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2022–FY2025

+63.7%

+17.86% a year

Each share's claim on the business

−38.9%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $9.59M

over 4 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

No 13F manager reports holding INDP.

Super Investors

Investment managers reporting INDP on Form 13F

No 13F manager reports holding INDP yet.

Institutional Funds

Mutual funds and ETFs reporting INDP on Form N-PORT; together they hold 0.3% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$126K	229.2K	0.17%	0.00%	March 31, 2025
FE Fidelity Extended Market Index Fund Fidelity Concord Street Trust	$22.7K	66.9K	0.05%	0.00%	May 31, 2025

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$126K

% of company

0.17%

% of the fund

0.00%

As of

March 31, 2025

Fidelity Extended Market Index Fund

Fidelity Concord Street Trust

Position value

$22.7K

% of company

0.05%

% of the fund

0.00%

As of

May 31, 2025

4 more funds behind a free account

See every fund holding Indaptus Therapeutics Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
YY Yao Yun 5%+ holder 13D · 27.3%	42.0M	31.51%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company31.510% Disclosed stake13D · 27.3% View the 13D/G filing →
SL Sino Lion Ventures Ltd 5%+ holder 13D · 25.3%	38.9M	29.19%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company29.190% Disclosed stake13D · 25.3% View the 13D/G filing →

Yao Yun

5%+ holder13D · 27.3%

42.0M

% of company

31.51%

Change vs last qtr

—

Held since

—

Sino Lion Ventures Ltd

5%+ holder13D · 25.3%

38.9M

% of company

29.19%

Change vs last qtr

—

Held since

—

9 more holders behind a free account

See every insider and 5%+ holder of Indaptus Therapeutics Inc.

Comments